Priority 14 from the Liver Glycogen Storage Disease (International) PSP
|UNCERTAINTY: How to prevent and/or treat neurological problems in patients with liver Glycogen Storage Disease? (JLA PSP Priority 14)|
|JLA question ID||0090/14|
As a result of acute and chronic periods of hypoglycemia in liver GSD, neurological symptoms can occur. This question emphasizes that more research is necessary to avoid these neurological complications.
For details of the evidence checked, please see the spreadsheet held on the JLA website.
|Health Research Classification System category||Metabolic and endocrine|
|Extra information provided by this PSP|
|Original uncertainty examples||How do we follow neurologic sequele and developement? ~ How do we monitor neurologic sequele and developement?|
|Submitted by||Patient, carer and healthcare professionals|
|PSP unique ID||0090|
|PSP name||International Glycogen Storage Disease PSP|
|Total number of uncertainties identified by this PSP||72 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)|
|Date of priority setting workshop||24 May 2019|